(E)-chlorogenic acid
(E)-chlorogenic acid
Overview
(E)-Chlorogenic acid (CGA; Wikidata: Q421964) is a naturally occurring hydroxycinnamic acid ester formed by the condensation of caffeic acid and quinic acid. It belongs to the broader class of Phenolic Acids and is one of the most abundant polyphenols found in the plant kingdom, occurring at particularly high concentrations in coffee beans, dandelion (Taraxacum officinale), chicory (Cichorium intybus), bamboo shoots, and numerous other botanical sources. The compound exists primarily as three positional isomers — 3-CQA, 4-CQA, and 5-CQA — depending on the site of esterification on the quinic acid ring, with 5-CQA (also designated as the (E)-isomer with respect to the trans-caffeic acid moiety) being the most prevalent in nature.
Biologically, (E)-chlorogenic acid is recognized for its potent antioxidant activity, mediated through free radical scavenging and metal chelation. It inhibits key metabolic enzymes including alpha-glucosidase and alpha-amylase (amylase alpha 1C), linking it mechanistically to the modulation of postprandial glucose absorption and its investigated utility in type 2 diabetes contexts. Beyond metabolic effects, CGA exhibits anti-inflammatory properties — partly through modulation of macrophage and microglial signaling — as well as antimicrobial, antiproliferative, and anti-aging activities in skin cells. Its structural relatedness to trans-caffeic acid, ferulic acid, and other Phenolic Acids places it within a well-characterized network of bioactive phytochemicals frequently studied alongside quercetin, luteolin, apigenin, naringenin, and gallic acid.
Focus of Latest Publications
Recent investigations have focused on chlorogenic acid's potential therapeutic applications in metabolic dysfunction, particularly in addressing obesity and type 2 diabetes. A mouse model study demonstrated that dietary chlorogenic acid supplementation significantly reduced serum cholesterol, triglycerides, and LDL cholesterol while improving glucose handling, effects mediated through downregulation of hepatic lipid metabolism genes and modulation of CD36-mediated lipid uptake. In a physiologically relevant co-culture model simulating liver-adipose tissue interactions, chlorogenic acid mitigated olanzapine-induced lipid accumulation and elevated glucose and triglyceride levels, positioning it as a potential pharmacological intervention for metabolic disorders. These findings underscore chlorogenic acid's dual action on both lipid and glucose homeostasis.
The mechanistic basis of chlorogenic acid's bioactivity has emerged as a central focus. A comprehensive multi-omics study revealed that chlorogenic acid exerts its metabolic effects by reshaping gut microbial composition, enriching beneficial taxa including Lactobacillus and Bacteroides while restoring key metabolites such as L-glutathione and chenodeoxycholic acid derivatives. Separately, chlorogenic acid has been identified as a major bioactive constituent in extracts from diverse plant sources—including sunflower meal, dandelion, Achillea arabica, and Bellis annua—where it contributes strong antioxidant capacity, prebiotic potential, and inhibition of α-glucosidase, alongside anti-inflammatory effects in lipopolysaccharide-stimulated microglia. Machine learning analyses have further enabled prediction of chlorogenic acid's radical-scavenging activity in complex botanical matrices, establishing its role as a primary determinant of antioxidant potency across multiple plant-derived preparations.
Quality assessment and analytical monitoring of chlorogenic acid have received substantial attention in supplement and food industries. Analysis of 23 commercial green coffee bean extract supplements revealed widespread inconsistencies in chlorogenic acid content—ranging from non-detectable to 31.15%—with widespread mislabelling and regulatory non-compliance, particularly regarding declared caffeine levels. Simultaneously, novel sensing technologies have been developed for chlorogenic acid detection, including silver-modified zeolite-based colorimetric approaches enabling quantitation in coffee wastewater and other matrices. These analytical advances reflect growing interest in standardizing and authenticating chlorogenic acid content across food and nutraceutical products.
Human consumption data and sensory characterization suggest that chlorogenic acid's physiological effects extend to sensory perception of beverages. Structural analysis of the caffeine-chlorogenic acid complex in coffee revealed that while the two compounds form complexes, this interaction does not directly modulate caffeine's bitter taste; instead, chlorogenic acid's interaction with high molecular weight coffee melanoidins substantially reduces bitter intensity, indicating potential applications in beverage formulation and consumer acceptance.